Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Merkel cell carcinoma.

Summer R Youker1

  • 1Department of Dermatology, Saint Louis University, St Louis, Missouri, USA.

Advances in Dermatology
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Merkel cell carcinoma requires aggressive, early treatment including surgery and radiation for best outcomes. While rare spontaneous regressions occur, prompt medical intervention offers the highest survival chance for this aggressive skin cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mohs frozen tissue sections in comparison to similar paraffin-embedded tissue sections in identifying perineural tumor invasion in cutaneous squamous cell carcinoma.

Journal of the American Academy of Dermatology·2012
Same author

The importance of reviewing pathology specimens before Mohs surgery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2009
Same author

Mounting the debulk specimen with the first layer: a time-saver in the Mohs unit.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2007
Same author

Elastosis perforans serpiginosa.

Skinmed·2007
Same author

Combined Merkel cell carcinoma and atypical fibroxanthoma.

Journal of cutaneous medicine and surgery·2005
Same author

White piedra: further evidence of a synergistic infection.

Journal of the American Academy of Dermatology·2003
Same journal

Uncommon benign infantile vascular tumors.

Advances in dermatology·2009
Same journal

Advances in hair diseases.

Advances in dermatology·2009
Same journal

Cutaneous mosaicism: a molecular and clinical review.

Advances in dermatology·2009
Same journal

Current concepts: dermatopathology of pigmentary alteration disorders in the Hispanic population.

Advances in dermatology·2009
Same journal

Recent advances in acne vulgaris research: insights and clinical implications.

Advances in dermatology·2009
Same journal

Update on the natural history and systemic treatment of psoriasis.

Advances in dermatology·2009
See all related articles

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Pathology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer.
  • Early and aggressive treatment is crucial for patient survival.
  • Spontaneous regression of MCC is rare, with only 5 reported cases.

Purpose of the Study:

  • To outline an aggressive, evidence-based treatment approach for Merkel cell carcinoma.
  • To emphasize the importance of early detection and comprehensive management strategies.

Main Methods:

  • Review of published literature on Merkel cell carcinoma treatment.
  • Recommendations for surgical management: wide local excision or Mohs' surgery.
  • Inclusion of sentinel lymph node biopsy and dissection for metastatic assessment.

Related Experiment Videos

  • Adjuvant radiation therapy to primary site and draining basin.
  • Consideration of chemotherapy for advanced or palliative cases.

    • Main Results:

    • Aggressive multimodal treatment, including surgery and radiation, is supported by limited literature.
    • Sentinel lymph node biopsy is key for staging and guiding further treatment.
    • Chemotherapy is primarily for palliation in advanced stages.

    Conclusions:

    • An aggressive treatment paradigm including surgery, sentinel lymph node biopsy, and adjuvant radiation offers the best chance of survival for Merkel cell carcinoma.
    • Further prospective trials and longer follow-up are needed for larger patient cohorts.